Skip to search formSkip to main contentSkip to account menu

febuprol

Known as: 3-butoxy-1-phenoxy-propanol-(2) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVE:To develop a HPLC method for the determination of the principal agent in febuprol pills.METHODS:The principal agent was… 
1991
1991
  • L. Rui
  • 1991
  • Corpus ID: 204578060
1988
1988
The effect of a new potent choleretic drug (Febuprol) on lipid composition and cholesterol nucleation time in gallbladder bile… 
1987
1987
10 patients with right upper quadrant pain were treated with a choleretic agent (Febuprol; 3 X 200 mg t. i. d.) and placebo in a… 
1983
1983
In a clinical trial, performed according to new criteria of the AMG (Arzneimittelgesetz) 1976, a new choleretic monosubstance 3-n… 
1978
1978
In previous pharmacological experiments with the choleretic agent Febuprol, healthy subjects showed a significant increase in… 
1977
1977
The spasmolytic activity of 3-butoxy-1-phenoxy-propanol-(2) (febuprol) on the biliary tract is demonstrated in two different… 
1976
1976
The pharmacokinetic behaviour as well as metabolization of 3-butoxy - 1 - phenoxy-propanol-(2) (febuprol) in rats and mice were… 
1976
1976
The choleretic effect of 3-butoxy-1-phenoxypropanol-(2), Febuprol (INN), was examined in healthy volunteer subjects. In a dose…